To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy
Clinical trial NCT06940336 · RECRUITING
Trial details
- NCT number
- NCT06940336
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-19
- Primary completion
- 2028-01-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.